These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
195 related articles for article (PubMed ID: 22065906)
1. Apoptotic effects of genistein, biochanin-A and apigenin on LNCaP and PC-3 cells by p21 through transcriptional inhibition of polo-like kinase-1. Seo YJ; Kim BS; Chun SY; Park YK; Kang KS; Kwon TG J Korean Med Sci; 2011 Nov; 26(11):1489-94. PubMed ID: 22065906 [TBL] [Abstract][Full Text] [Related]
2. A concentrated aglycone isoflavone preparation (GCP) that demonstrates potent anti-prostate cancer activity in vitro and in vivo. Bemis DL; Capodice JL; Desai M; Buttyan R; Katz AE Clin Cancer Res; 2004 Aug; 10(15):5282-92. PubMed ID: 15297432 [TBL] [Abstract][Full Text] [Related]
3. Involvement of nuclear factor-kappa B, Bax and Bcl-2 in induction of cell cycle arrest and apoptosis by apigenin in human prostate carcinoma cells. Gupta S; Afaq F; Mukhtar H Oncogene; 2002 May; 21(23):3727-38. PubMed ID: 12032841 [TBL] [Abstract][Full Text] [Related]
4. Low-dose genistein induces cyclin-dependent kinase inhibitors and G(1) cell-cycle arrest in human prostate cancer cells. Shen JC; Klein RD; Wei Q; Guan Y; Contois JH; Wang TT; Chang S; Hursting SD Mol Carcinog; 2000 Oct; 29(2):92-102. PubMed ID: 11074606 [TBL] [Abstract][Full Text] [Related]
5. Activation of GPR30 inhibits the growth of prostate cancer cells through sustained activation of Erk1/2, c-jun/c-fos-dependent upregulation of p21, and induction of G(2) cell-cycle arrest. Chan QK; Lam HM; Ng CF; Lee AY; Chan ES; Ng HK; Ho SM; Lau KM Cell Death Differ; 2010 Sep; 17(9):1511-23. PubMed ID: 20203690 [TBL] [Abstract][Full Text] [Related]
6. Increased therapeutic potential of an experimental anti-mitotic inhibitor SB715992 by genistein in PC-3 human prostate cancer cell line. Davis DA; Sarkar SH; Hussain M; Li Y; Sarkar FH BMC Cancer; 2006 Jan; 6():22. PubMed ID: 16433906 [TBL] [Abstract][Full Text] [Related]
7. Effect of flavonoids on cell cycle progression in prostate cancer cells. Kobayashi T; Nakata T; Kuzumaki T Cancer Lett; 2002 Feb; 176(1):17-23. PubMed ID: 11790449 [TBL] [Abstract][Full Text] [Related]
8. Suppression of constitutive and tumor necrosis factor alpha-induced nuclear factor (NF)-kappaB activation and induction of apoptosis by apigenin in human prostate carcinoma PC-3 cells: correlation with down-regulation of NF-kappaB-responsive genes. Shukla S; Gupta S Clin Cancer Res; 2004 May; 10(9):3169-78. PubMed ID: 15131058 [TBL] [Abstract][Full Text] [Related]
9. Honokiol causes G0-G1 phase cell cycle arrest in human prostate cancer cells in association with suppression of retinoblastoma protein level/phosphorylation and inhibition of E2F1 transcriptional activity. Hahm ER; Singh SV Mol Cancer Ther; 2007 Oct; 6(10):2686-95. PubMed ID: 17938262 [TBL] [Abstract][Full Text] [Related]
10. Genistein induces cell growth inhibition in prostate cancer through the suppression of telomerase activity. Ouchi H; Ishiguro H; Ikeda N; Hori M; Kubota Y; Uemura H Int J Urol; 2005 Jan; 12(1):73-80. PubMed ID: 15661057 [TBL] [Abstract][Full Text] [Related]
11. In vitro studies on the modification of low-dose hyper-radiosensitivity in prostate cancer cells by incubation with genistein and estradiol. Hermann RM; Wolff HA; Jarry H; Thelen P; Gruendker C; Rave-Fraenk M; Schmidberger H; Christiansen H Radiat Oncol; 2008 Jul; 3():19. PubMed ID: 18625043 [TBL] [Abstract][Full Text] [Related]
12. Mechanisms of the growth inhibitory effects of the isoflavonoid biochanin A on LNCaP cells and xenografts. Rice L; Samedi VG; Medrano TA; Sweeney CA; Baker HV; Stenstrom A; Furman J; Shiverick KT Prostate; 2002 Aug; 52(3):201-12. PubMed ID: 12111696 [TBL] [Abstract][Full Text] [Related]
13. Identification of both Myt-1 and Wee-1 as necessary mediators of the p21-independent inactivation of the cdc-2/cyclin B1 complex and growth inhibition of TRAMP cancer cells by genistein. Touny LH; Banerjee PP Prostate; 2006 Oct; 66(14):1542-55. PubMed ID: 16924665 [TBL] [Abstract][Full Text] [Related]
14. Indole-3-carbinol (I3C) induced cell growth inhibition, G1 cell cycle arrest and apoptosis in prostate cancer cells. Chinni SR; Li Y; Upadhyay S; Koppolu PK; Sarkar FH Oncogene; 2001 May; 20(23):2927-36. PubMed ID: 11420705 [TBL] [Abstract][Full Text] [Related]
15. Inhibitory effect of isoflavones on prostate cancer cells and PTEN gene. Cao F; Jin TY; Zhou YF Biomed Environ Sci; 2006 Feb; 19(1):35-41. PubMed ID: 16673816 [TBL] [Abstract][Full Text] [Related]
16. Down-regulation of Skp2 is correlated with p27-associated cell cycle arrest induced by phenylacetate in human prostate cancer cells. Shibahara T; Onishi T; Franco OE; Arima K; Sugimura Y Anticancer Res; 2005; 25(3B):1881-8. PubMed ID: 16158921 [TBL] [Abstract][Full Text] [Related]
17. [The role of mitogen-activated protein kinase cascades in inhibition of proliferation in human prostate carcinoma cells by raloxifene: an in vitro experiment]. Zhang YX; Kong CZ Zhonghua Yi Xue Za Zhi; 2008 Jan; 88(4):271-5. PubMed ID: 18361842 [TBL] [Abstract][Full Text] [Related]
18. Molecular effects of soy phytoalexin glyceollins in human prostate cancer cells LNCaP. Payton-Stewart F; Schoene NW; Kim YS; Burow ME; Cleveland TE; Boue SM; Wang TT Mol Carcinog; 2009 Sep; 48(9):862-71. PubMed ID: 19263441 [TBL] [Abstract][Full Text] [Related]
19. Inhibition of prostaglandin synthesis and actions by genistein in human prostate cancer cells and by soy isoflavones in prostate cancer patients. Swami S; Krishnan AV; Moreno J; Bhattacharyya RS; Gardner C; Brooks JD; Peehl DM; Feldman D Int J Cancer; 2009 May; 124(9):2050-9. PubMed ID: 19127598 [TBL] [Abstract][Full Text] [Related]
20. Arsenic trioxide induces apoptosis in NB-4, an acute promyelocytic leukemia cell line, through up-regulation of p73 via suppression of nuclear factor kappa B-mediated inhibition of p73 transcription and prevention of NF-kappaB-mediated induction of XIAP, cIAP2, BCL-XL and survivin. Momeny M; Zakidizaji M; Ghasemi R; Dehpour AR; Rahimi-Balaei M; Abdolazimi Y; Ghavamzadeh A; Alimoghaddam K; Ghaffari SH Med Oncol; 2010 Sep; 27(3):833-42. PubMed ID: 19763917 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]